iCAD · 3 hours ago
Regulatory Affairs Consultant (FDA)
Maximize your interview chances
Insider Connection @iCAD
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Focus on new product FDA pre submission and submission work
Work with a cross-function team to prepare the documents for collection of both a pre-submission request for the subject device and a 510K submission for the subject device
Review previous presubs to ensure thorough history of device
Review FOIA package
Provide any insights for presub
Work cross functionally to create the subject device’s device description to be used for the pre-submission
Review and comment on protocol to be used to support device performance
Confirm applicable standards
Create draft questions
Work cross functionally to develop the PCCP
Work cross functionally to support label development
Work cross functionally to develop HFE protocol
Review FOIA for guidance on templates for required documents
Cross functional deliverables
Prepare for meeting
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
3-5 years of 510K submission work in radiology
2-3 successful 510K submissions for software devices
Working knowledge of cybersecurity requirements
Strong knowledge of SDLC (software development life cycle)
Strong communicator
Experience with human factors studies
Experience working with OHT8 (radiology) on software as a medical device
Experience using both preSTAR and eSTAR
Company
iCAD
iCAD is a medical technology that offers cancer detection and therapy solutions.
H1B Sponsorship
iCAD has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$59.5M2021-03-03Post Ipo Equity· $22M
2020-04-28Post Ipo Equity· $12.5M
2019-06-18Post Ipo Equity· $10M
Recent News
GlobeNewswire News Room
2024-11-13
GlobeNewswire News Room
2024-06-04
2024-05-23
Company data provided by crunchbase